Form 4 for PFE Pfizer
Accepted 2022-12-16 00:00:00 ET · period of report 2022-12-15 · accession 0001225208-22-012885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-16 | 2022-12-16 | PFE | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $27.25 | +222.3K | 411.9K | +117% | +$6.06M |
| DM | 2022-12-16 | 2022-12-16 | PFE | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $0.00 | -431.1K | 0 | -100% | $0 |
| D | 2022-12-16 | 2022-12-15 | PFE | BOURLA ALBERT | COB, CEO, Dir | A - Grant | $53.61 | +10 | 96.4K | +0.0% | +$536.10 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | M | A | 133,172 | $30.17 | 322,734 | D | — | — | (F1) Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $50.68)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant. |
| 2 | Common | Common Stock | 2022-12-16 | M | A | 89,156 | $22.89 | 411,890 | D | — | — | (F2) Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $50.68)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant. |
| 3 | Derivative | Stock Appreciation Rights | 2022-12-16 | M | D | 145,970 | $0.00 | 0 | D | $22.89 · 2019-02-25 to 2023-02-25 | 145,970 Common Stock | |
| 4 | Derivative | Phantom Stock Units SSP | 2022-12-15 | A | A | 10 | $53.61 | 96,391 | D | — · — to — | 10 Common Stock | (F3) Each unit represents one phantom share of common stock. (F4) These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
| 5 | Derivative | Stock Appreciation Rights | 2022-12-16 | M | D | 285,161 | $0.00 | 0 | D | $30.17 · 2021-02-22 to 2023-02-22 | 285,161 Common Stock |